Evaluation of the antisecretory effect of a new anticholinergic agent--heteronium bromide.
D000368:Aged; D000704:Analysis of Variance; D002986:Clinical Trials as Topic; D004381:Duodenal Ulcer / Q000188:drug therapy; D005260:Female; D005745:Gastric Acidity Determination; D005750:Gastric Juice / Q000187:drug effects / Q000378:metabolism*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010276:Parasympatholytics / Q000008:administration & dosage / Q000494:pharmacology*; D010919:Placebos; D011413:Propantheline / Q000494:pharmacology; D011759:Pyrrolidines / Q000008:administration & dosage / Q000494:pharmacology*; D013270:Stomach / Q000187:drug effects*; D013876:Thiophenes / Q000008:administration & dosage / Q000494:pharmacology*
D010276:Parasympatholytics; D010919:Placebos; D011759:Pyrrolidines; D013876:Thiophenes; D011413:Propantheline